Individual-based modeling reveals that the COVID-19 isolation period can be shortened by community vaccinationArticle Published on 2022-10-202022-11-16 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI approach B.1.617.2 baseline BNT162b2 vaccine booster vaccination Community Contact COVID-19 Delta Effect effective vaccine emotional Impact individual infected individual infected individuals Infection Isolation less likelihood mitigate nonpharmaceutical intervention occur outbreak profile Psychological quarantine reduce reveal risk Secondary infection subsequent sustained the patient the SARS-CoV-2 Transmission transmission of SARS-CoV-2 vaccination Vaccine-induced immunity variant Viral load [DOI] 10.1038/s41598-022-21645-y PMC 바로가기
[Risk perception, information received and occupational engagement of workers in a university hospital in the face of the COVID-19 pandemic]Article Published on 2022-10-202023-07-10 Journal: Revista Latino-Americana de Enfermagem [Category] COVID19(2023년), [키워드] COVID-19 Epidemiology Healthcare workers information risk Spain Work engagement
Modifications to student quarantine policies in K-12 schools implementing multiple COVID-19 prevention strategies restores in-person education without increasing SARS-CoV-2 transmission risk, January-March 2021Article Published on 2022-10-202022-11-16 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 치료기술, [키워드] adjusted Asymptomatic close contact Community conducted COVID-19 COVID-19 case Cox regression model determine event hazard ratio incidence incidence of COVID-19 increase in K-12 no difference occurred offered participant prospective cohort study public schools quarantine reduce risk RT-PCR testing SARS-COV-2 infection SARS-CoV-2 transmission School tested Transmission [DOI] 10.1371/journal.pone.0266292 PMC 바로가기
Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysisArticle Published on 2022-10-202022-11-15 Journal: Scientific Reports [Category] COVID19(2023년), meta-analysis, SARS, 변종, 진단, [키워드] absolute reduction article baseline Bayesian comparable Comparative COVID-19 Effect effective Effectiveness Efficacy Evidence expected generalisability healthcare high risk hospitalisation ICU admission identify individual infected individual infected with SARS-CoV-2 invasive ventilation moderate monoclonal antibody Mortality network Network meta-analysis neutralising outcome Pairwise comparison patient population patients patients treated Placebo predict Rate RCT reaction reduce mortality reducing reduction in relative risk risk reduction serious AE severe COVID-19 statistically significant reduction systematic review therapy treatment effect vaccination variant [DOI] 10.1038/s41598-022-22431-6 PMC 바로가기
The SARS-CoV-2 Infection Among Students in the University of Porto: A Cross-Sectional StudyArticle Published on 2022-10-202022-11-15 Journal: International Journal of Public Health [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI age antibodies applied Bayesian inference Contact Evidence groups IgG IgG antibody IgM Immunoglobulin immunological Infection International interval Local male Molecular diagnosis molecular test Older point of care Porto Prevalence quarantine questionnaire reactive reported risk SARS-CoV-2 SARS-CoV-2 specific antibody Seroepidemiology Seroprevalence significantly higher student Symptoms university university students was performed [DOI] 10.3389/ijph.2022.1604548 PMC 바로가기
Prevalence of SARS-CoV-2 infection and associated risk factors: A testing program and nested case-control study conducted at Sapienza University of Rome between March and June 2021Article Published on 2022-10-192022-11-15 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 치료기술, [키워드] 95% CIs 95% confidence interval activity Administered Analysis calculated Case-control case-control study Community comparable conducted contributed controls COVID-19 COVID-19 case COVID-19 pandemic Factor Gender identify Infection Infection prevention investigated likelihood limit Logistic regression measure Measures molecular test Monday multivariable analysis Odds ratio offered participant performed positive reached reduce resources risk risk factor Risk factors Rome Safe SARS-COV-2 infection SARS-CoV-2 testing statistical significance statistically significant students testing program Thursday university virus transmission were excluded [DOI] 10.3389/fpubh.2022.1010130 PMC 바로가기
The failure of drug repurposing for COVID-19 as an effect of excessive hypothesis testing and weak mechanistic evidenceArticle Published on 2022-10-182022-11-16 Journal: History and philosophy of the life sciences [Category] COVID19(2023년), SARS, 신약개발, [키워드] agency Analysis applied approval clinical trial Compound conducted COVID COVID-19 EBM+ effective Efficacy Evidence example Excessive hypothesis testing explain false-positive result False-positive results favor Hydroxychloroquine Hypothesis less Mechanistic evidence Medical nihilism. Medicine ongoing trial other diseases Perspective risk second tested therapeutic therapy Treatment treatment for COVID-19 Trial [DOI] 10.1007/s40656-022-00532-9 PMC 바로가기
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancerArticle Published on 2022-10-182022-11-15 Journal: Cell Reports Medicine [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] addition Blood Blood cancer Breakthrough infection Cancer CAPTURE study COVID-19 COVID-19 vaccine Delta detectable dose greater immune response Infection Live virus marker microneutralization NAb titer NAbT Neutralizing Neutralizing antibodies Neutralizing antibody titer of BNT162b2 omicron Patient proportion risk SARS-CoV-2 SARS-CoV-2 variant severe COVID-19 disease T cell response T cells therapy vaccination vaccine dose variants of concern wild-type [DOI] 10.1016/j.xcrm.2022.100781 PMC 바로가기
Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19Article Published on 2022-10-172022-11-16 Journal: Frontiers in Cellular and Infection Microbiology [Category] meta-analysis, [키워드] 28-day mortality Analysis analyzed Anti-inflammatory anti-inflammatory drug benefit Clinical outcome clinical outcomes clinical status coronavirus disease COVID-19 COVID-19 pandemic decrease discharge Evidence hazard ratio hospital discharge Hospitalized hospitalized patient In-hospital medication Meta-analysis Mortality non-steroidal anti-inflammatory drug Nonsteroidal anti-inflammatory drugs NSAID NSAIDS outcome Patient patients with COVID-19 performed post-hoc question raised receive risk Safe severe COVID-19 severity significant increase survival Treatment Trial two group with COVID-19 [DOI] 10.3389/fcimb.2022.935280 PMC 바로가기
Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2Article Published on 2022-10-172022-11-16 Journal: The Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome Admission Against booster coronavirus coronavirus 2 COVID-19 Cox proportional hazard Czech Republic declined Delta Effectiveness evade Hospitalization Immunity Infection infections intensive care Logistic regression need for oxygen Odds ratio omicron Omicron variant outcome oxygen Postinfection postinfection immunity protection reached recent respiratory risk SARS-CoV-2 therapy vaccination Vaccine vaccine effectiveness variant [DOI] 10.1093/infdis/jiac161 PMC 바로가기